Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03198026
Brief Title: Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas

First Submitted : June 22, 2017
First Submitted that Met QC Criteria : June 22, 2017
First Posted : June 23, 2017

Last Update Submitted that Met QC Criteria : February 28, 2019
Last Update Posted : March 4, 2019